510(k) K203248
K203248 is an FDA 510(k) premarket notification submitted by Abbott Ireland Diagnostics Division for the device "Albumin BCG2". The FDA issued a decision of Substantially Equivalent on November 23, 2021. The device falls under product code CIX (Bromcresol Green Dye-Binding, Albumin), a Class II device regulated under 21 CFR 862.1035. Abbott Ireland Diagnostics Division has at least 7 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 23, 2021
- Date Received
- November 4, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Bromcresol Green Dye-Binding, Albumin
- Device Class
- Class II
- Regulation Number
- 862.1035
- Review Panel
- CH
- Submission Type